Jury Rules in Favor of ClearOne in Shure Patent Trial

ClearOne Shure1

In a press release published Thursday, ClearOne announced that a jury in the U.S. District Court for the District of Delaware returned a verdict of no infringement by ClearOne’s Ceiling Tile Beamforming Mic Array product line on Shure Incorporated’s U.S. Patent No. D865,723 (the “’723 patent”). The jury also declared the “’723 patent” to be invalid.

In the case, Shure accused ClearOne of infringement on its BMA CT, Versa Pro CTCOLLABORATE Versa Lite CTCOLLABORATE Versa Room CT), BMA 360 and BMA-CTX (“Xceed”) products.

The two companies have been in a string of legal battles since 2017. The longstanding series of trials began in the U.S. District Court for the Northern District of Illinois, where ClearOne asserted that Shure infringes U.S. Patent No. 9,635,186 and U.S. Patent No. 9,813,806, directed at a BMA integrated into a ceiling tile.

“The jury’s unanimous verdict is the latest in a string of litigation victories for ClearOne against Shure,” said Zee Hakimoglu, president and CEO of ClearOne, in the press release published this morning. “We are very pleased that the jury found that ClearOne’s BMA CT products did not infringe and invalidated Shure’s patent. Shure was using the ’723 patent to retaliate against ClearOne, and the jury’s verdict validates ClearOne’s refusal to give in to Shure’s tactics.”

rAVe requested a statement regarding the trial decision from Shure. A copy of the company’s statement can be seen below:

“Shure is disappointed by the jury’s finding that our ‘723 patent is not valid, and was not infringed. We believe the United States Patent Office correctly recognized Shure’s novel design when it issued the ‘723 patent, and ClearOne’s BMA CT products infringe that design. We intend to appeal both rulings.”